China clears its first drug for chronic hepatitis D
Huahui Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus.
Boehringer signs €1bn+ deal for Simcere IBD candidate
Boehringer Ingelheim has sourced an IL-23p19xTL1A bispecific antibody for inflammatory bowel disease, from China's Simcere, for €42m upfront.
Roche claims midstage win for obesity injectable
Roche reports weight loss of up to 22.5% with its injectable GIP/GLP-1 agonist obesity drug, setting up phase 3, but will it be too late to the table?
Vaccination fall costs UK its measles elimination status
The UK has lost its measles elimination status, according to the WHO, due to a spike in cases in 2024 and a fall in vaccination coverage.
Introducing the Sunday Times Tech 100: Life sciences part 2
In our second of three reports on the 2026 Sunday Times Tech 100, we focus on the first nine of 18 life sciences companies in the hardware category.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
Book your tickets and join the PM Society for the 40th PM Aw...
Tickets are on sale for the 40th anniversary of the PM Awards
The Pharmaceutical Manufacturing and Packaging Congress (PHA...
The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2026 unites professionals to discuss the most recent trends of industry in Amsterdam
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
VuuAI and Amiculum partner to transform content engagement i...
Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation plat
10th Tumor Models Summit San Francisco
Join the West Coast's premier pharma and biotech gathering, the 10th Tumor Models Summit San Francisco, where innovation meets opportunity